IP Library Granted Patent US 12702524
Granted Patent B2
US 12702524 · App. 17/115,568 · Granted Aug 11, 2026

Template and method for removing a tattoo through patterned trans-epidermal pigment release

Inventors: Jack H. Savage (Sandy, UT); Timothy N. Turner (West Jordan, UT); Gregg D. Niven (Kaysville, UT)
Assignee: Rejuvatek Medical Inc.
A61B90/39A61B17/00A61F7/00A61B2017/00769A61B2090/395A61N5/062A61N5/10A61N7/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12702524
App. No.
17/115,568
Granted
Aug 11, 2026
Kind
B2
Abstract

Embodiments of a method for removing a tattoo through patterned trans-epidermal pigment release includes determining first treatment area of skin of a patient through a primary template including primary apertures, marking the first treatment area of skin of the patient along borders of the primary apertures to outline a grid of primary tegulae, and delivering a tattoo removal fluid to the marked first exposed skin. In an alternate embodiment, a template, which may be adhered to the skin, is used during a disruption process to create a structured, patterned procedure to remove skin irregularities. The template has a plurality of needle apertures, an adhesive layer, and a release liner. The release liner may be removed, exposing the adhesive layer, so that the template, with the plurality of needle apertures, may be positioned over the skin irregularity.

Claims (31)

1 . A method for removing a skin marking using dermal disruption, the method comprising:

scanning an area of skin of a patient to be treated, wherein the area of skin has not previously undergone dermal disruption to remove the skin marking;

determining a first treatment area of skin of a patient using a primary template, the primary template providing indicia upon the patient's skin defining primary tegulae, wherein a diameter of the primary tegulae is calculated based at least in part on information regarding pigmentation determined by the scan;

disrupting the tissue in the primary tegulae to form a first eschar in a first treatment session;

determining a second treatment area of skin for treatment subsequent to treatment of the first treatment area using a secondary template, the secondary template marking secondary tegulae interposed between primary tegulae; and

disrupting the tissue in the secondary tegulae to form a second eschar in a second treatment session.

2 . The method of claim 1 , wherein disrupting the tissue in the secondary tegulae isolates a plurality of remaining skin marking areas in a grid of tertiary tegulae, and wherein the method further comprises disrupting the tissue in the tertiary tegulae in a third treatment session.

3 . The method of claim 1 , wherein the secondary tegulae are non-circular and non-polygonal.

4 . The method of claim 1 , wherein the primary template comprises a flexible, non-stretchable sheet of material.

5 . The method of claim 1 , wherein the primary template comprises an image projected upon the patient's skin.

6 . The method of claim 1 , wherein the step of disrupting the tissue comprises applying a mechanical disruption of the tissue.

7 . The method of claim 1 , wherein the step of disrupting the tissue comprises applying a temperature change to the tissue.

8 . The method of claim 7 , wherein a temperature of a probe used in applying the temperature change is used to control the depth of tissue disruption at least in part.

9 . The method of claim 1 , wherein the step of disrupting the tissue comprises applying a chemical agent to the tissue.

10 . The method of claim 1 , wherein the step of disrupting the tissue comprises applying radiation to the tissue.

11 . The method of claim 10 , wherein the primary template comprises a reflective portion that resisting energy deposition in an area covered by the reflective portion.

12 . The method of claim 1 , wherein the step of disrupting the tissue comprises applying focused waves to the tissue.

13 . The method of claim 12 , wherein a frequency of the focused waves is used to control the depth of tissue disruption at least in part.

14 . The method of claim 1 , wherein the step of disrupting the tissue comprises applying focused particles to the tissue.

15 . The method of claim 1 , wherein disrupting the tissue comprises applying variable energy to the area to be treated, and wherein less pigmented areas receive relatively less energy than more deeply pigmented areas.

16 . The method of claim 1 , wherein natural features of the area to be treated are used as registration marks to orient the primary template.

17 . A method for removing a skin marking using dermal disruption, the method comprising:

scanning an area of skin of a patient to be treated, wherein the area of skin has not previously undergone dermal disruption to remove the skin marking;

providing indicia indicative of a template on skin of a patient, the template comprising indicia of a primary lattice tegulae between secondary tegulae;

disrupting the tissue within the primary lattice tegulae to form a first eschar in a first treatment session that isolates the secondary tegulae;

disrupting the tissue in the secondary tegulae to form a second eschar in a second treatment session subsequent to the first treatment session;

wherein a diameter of each of the primary lattice tegulae is calculated based at least in part on information regarding pigmentation determined by the scan.

18 . The method of claim 1 , wherein the skin marking comprises a tattoo.

19 . The method of claim 1 , wherein the skin marking comprises a skin irregularity.

20 . The method of claim 19 , wherein the skin irregularity comprises a skin lesion.

21 . The method of claim 19 , wherein the skin irregularity comprises stretch marks.